Total Payments
$400,808
2024 Payments
$76,154
Companies
24
Transactions
187
Payment Breakdown by Category
Consulting$369,450 (92.2%)
Travel$15,391 (3.8%)
Other$11,350 (2.8%)
Food & Beverage$4,617 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $369,450 | 102 | 92.2% |
| Travel and Lodging | $15,391 | 38 | 3.8% |
| Honoraria | $10,350 | 5 | 2.6% |
| Food and Beverage | $4,617 | 40 | 1.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000 | 1 | 0.2% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$400,808
186 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sage Therapeutics, Inc. | $183,262 | 66 | $0 (2024) |
| ITI, Inc. | $100,000 | 39 | $0 (2023) |
| Magstim Group Inc. | $33,918 | 12 | $0 (2018) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27,500 | 11 | $0 (2024) |
| Mylan Inc. | $10,061 | 10 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $9,565 | 3 | $0 (2024) |
| LivaNova USA, Inc. | $8,228 | 6 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $7,429 | 9 | $0 (2024) |
| SK Life Science, Inc. | $4,800 | 4 | $0 (2021) |
| Almatica Pharma LLC | $2,755 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76,154 | 25 | Sage Therapeutics, Inc. ($40,569) |
| 2023 | $109,177 | 52 | Sage Therapeutics, Inc. ($54,791) |
| 2022 | $88,723 | 40 | Sage Therapeutics, Inc. ($54,652) |
| 2021 | $64,700 | 32 | Sage Therapeutics, Inc. ($30,953) |
| 2020 | $26,952 | 20 | ITI, Inc. ($12,500) |
| 2019 | $82.11 | 2 | Tris Pharma Inc ($64.66) |
| 2018 | $12,103 | 4 | Magstim Group Inc. ($11,000) |
| 2017 | $22,918 | 12 | Magstim Inc. ($22,918) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Sage Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ACADIA Pharmaceuticals Inc | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Sage Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $851.62 | General |
| 09/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/29/2024 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $241.89 | General |
| 07/27/2024 | Sage Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $990.00 | General |
| 07/26/2024 | Sage Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $726.95 | General |
| 07/26/2024 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $86.00 | General |
| 07/26/2024 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $78.00 | General |
| 07/26/2024 | Sage Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $77.00 | General |
| 07/26/2024 | Sage Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $17.28 | General |
| 07/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Sage Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 04/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/16/2024 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $4,387.50 | General |
| 02/16/2024 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $2,997.50 | General |
| 02/08/2024 | Sage Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 01/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: PSYCHIATRY | ||||||
About Charles Nemeroff, MD PHD
Charles Nemeroff, MD PHD is a Psychiatry healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1326228347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charles Nemeroff, MD PHD has received a total of $400,808 in payments from pharmaceutical and medical device companies, with $76,154 received in 2024. These payments were reported across 187 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($369,450).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Austin, TX
- Active Since 11/07/2007
- Last Updated 08/12/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1326228347
Products in Payments
- CAPLYTA (Drug) $127,500
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $8,228
- NUPLAZID (Drug) $5,729
- Cenobamate (Drug) $3,200
- LOREEV XR (Drug) $2,755
- IGALMI (Drug) $2,680
- ABILIFY MAINTENA (Drug) $2,000
- XCOPRI (Drug) $1,600
- Korlym (Drug) $1,425
- Assurity Pacemaker (Device) $102.59
- Dyanavel XR (Drug) $64.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Austin
Dr. Donald Garcia, Md, MD
Psychiatry — Payments: $4.0M
Psychiatry $4.0M
Dr. Arvinder Pal Walia, M.d, M.D
Psychiatry — Payments: $2.7M
Psychiatry $2.7M
Dr. Divyansu Patel, M.d, M.D
Psychiatry — Payments: $319,461
Psychiatry $319,461
Frank Floca, Md, MD
Psychiatry — Payments: $99,177
Psychiatry $99,177
Dr. Charles Sweet, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $88,371
Psychiatry $88,371
Dr. David Brown, M.d, M.D
Psychiatry — Payments: $45,241
Psychiatry $45,241